Search Results - "CHARTER Group"

Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change.

Authors: Cysique, LucetteA. Franklin, Donald Abramson, Ian et al.

Source: Journal of Clinical & Experimental Neuropsychology. Jun2011, Vol. 33 Issue 5, p505-522. 18p. 15 Charts, 2 Graphs.

Subjects: Cognition disorders, Central nervous system, Cognitive ability, Neuropsychological tests, Regression analysis

Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individuals.

Authors: Lin, Kenny Taylor, MichaelJ Heaton, Robert et al.

Source: Journal of Clinical & Experimental Neuropsychology. Mar2011, Vol. 33 Issue 3, p326-334. 9p. 5 Charts.

Subjects: Brain injuries, Metabolites, HIV-positive persons, Cognition disorders, Magnetic resonance, HIV infections

Characterizing HIV Medication Adherence for Virologic Success Among Individuals Living With HIV/AIDS: Experience With the CNS HIV Antiretroviral Therapy Effects Research ( CHARTER ) Cohort.

Authors: Biswas, Bipasha Spitznagel, Edward Collier, Ann C. et al.

Source: Journal of HIV/AIDS & Social Services. Jan-Mar2014, Vol. 13 Issue 1, p8-25. 18p.

Subjects: Chi-squared test, Clinical medicine research, Confidence intervals, Mental depression, Drugs, Epidemiology, HIV infections, Health outcome assessment, Patient compliance, Questionnaires, Research funding, Scale analysis (Psychology), Self-evaluation, Statistics, T-test (Statistics), Data analysis, Secondary analysis, Socioeconomic factors, Highly active antiretroviral therapy, Treatment effectiveness, Cross-sectional method, Descriptive statistics, CD4 lymphocyte count

Geographic Terms: California

White matter damage, neuroinflammation, and neuronal integrity in HAND.

Authors: Alakkas, Aljoharah Ellis, Ronald J. Watson, Caitlin Wei-Ming et al.

Source: Journal of NeuroVirology. Feb2019, Vol. 25 Issue 1, p32-41. 10p.

Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.

Authors: Anderson, Albert M. Muñoz-Moreno, Jose A. McClernon, Daniel R. et al.

Source: Journal of Infectious Diseases. Jan2017, Vol. 215 Issue 1, p105-113. 9p.

Etravirine in CSF is highly protein bound.

Authors: Nguyen, Anh Rossi, Steven Croteau, David et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). May2013, Vol. 68 Issue 5, p1161-1168. 8p.

Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration.

Authors: Croteau D Rossi SS Best BM et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). Mar2013, Vol. 68 Issue 3, p684-689. 6p.